Advances in Cell Therapy of Neurodegenerative Diseases

A special issue of Brain Sciences (ISSN 2076-3425). This special issue belongs to the section "Neurodegenerative Diseases".

Deadline for manuscript submissions: closed (15 July 2024) | Viewed by 5955

Special Issue Editor


E-Mail Website
Guest Editor
Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol 47176-47754, Iran
Interests: neurodegenerative diseases; molecular and cellular neuroscience; neuropharmacology

Special Issue Information

Dear Colleagues,

Neurodegenerative diseases are caused by progressive loss of structure and/or function of neurons. The lack of efficient therapies for neurodegenerative disorders leads to a significant burden on society and a high economic impact. Over the past 20 years, stem cell therapy has emerged as a promising strategy for treating neurodegenerative diseases.

This Special Issue of Brain Sciences aims to present a collection of studies detailing the most recent progress of stem cell treatments in neurodegenerative diseases. Authors are invited to submit research articles including experimental and clinical studies and reviews that address a broad range of topics related to cell therapy in neurodegenerative disorders.

Dr. Maryam Ghasemi-Kasman
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Brain Sciences is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Alzheimer’s disease
  • Parkinson’s disease
  • amyotrophic lateral sclerosis
  • Huntington’s disease
  • multiple sclerosis
  • embryonic stem cells
  • induced pluripotent stem cells
  • mesenchymal stem cells
  • direct reprogramming

Published Papers (2 papers)

Back to TopTop